Companies / Evolent Health, Inc. / Activity
Activity — Evolent Health, Inc.
25 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Mar 3, 2026 | Blackley Seth CEO | Other | Class A Common Stock | $84.4K | -24K -2.79% | 836,962 0.74% of shares | low |
| Mar 3, 2026 | McCarthy Daniel Joseph Executive | Other | Class A Common Stock | $84.3K | -24K -5.37% | 423,022 0.37% of shares | low |
| Mar 2, 2026 | McCarthy Daniel Joseph Executive | Other | Class A Common Stock | $65.1K | -18K -3.91% | 447,049 0.40% of shares | low |
| Mar 2, 2026 | Blackley Seth CEO | Other | Class A Common Stock | $63.5K | -18K -2.02% | 861,015 0.76% of shares | low |
| Mar 1, 2026 | Blackley Seth CEO | Other | Class A Common Stock | $31.0K | -10K -1.15% | 819,830 0.73% of shares | low |
| Mar 3, 2026 | Weinberg Jonathan Executive | Other | Class A Common Stock | $29.0K | -8K -3.27% | 244,512 0.22% of shares | low |
| Mar 1, 2026 | McCarthy Daniel Joseph Executive | Other | Class A Common Stock | $25.4K | -8K -1.80% | 425,960 0.38% of shares | low |
| Mar 3, 2026 | Shams Aammaad Executive | Other | Class A Common Stock | $15.1K | -4K -6.06% | 66,847 0.06% of shares | low |
| Mar 1, 2026 | Weinberg Jonathan Executive | Other | Class A Common Stock | $14.3K | -4K -1.73% | 249,773 0.22% of shares | low |
| Mar 1, 2026 | Shams Aammaad Executive | Other | Class A Common Stock | $8.4K | -3K -3.54% | 70,322 0.06% of shares | low |
| Mar 2, 2026 | Weinberg Jonathan Executive | Other | Class A Common Stock | $6.8K | -2K -0.74% | 252,787 0.22% of shares | low |
| Mar 2, 2026 | Shams Aammaad Executive | Other | Class A Common Stock | $3.0K | -850 -1.18% | 71,158 0.06% of shares | low |
| Jun 4, 2026 | Grua Peter J Director | Grant | Class A Common Stock | $0 | +41K +186.98% | 63,075 0.06% of shares | low |
| Jun 4, 2026 | Guertin Shawn M Director | Grant | Class A Common Stock | $0 | +41K +186.98% | 63,075 0.06% of shares | low |
| Mar 2, 2026 | Shams Aammaad Executive | Grant | Class A Common Stock | $0 | +2K +2.40% | 72,008 0.06% of shares | low |
| Mar 2, 2026 | Blackley Seth CEO | Grant | Class A Common Stock | $0 | +59K +7.19% | 878,751 0.78% of shares | low |
| Mar 2, 2026 | Weinberg Jonathan Executive | Grant | Class A Common Stock | $0 | +5K +1.97% | 254,683 0.23% of shares | low |
| Mar 2, 2026 | McCarthy Daniel Joseph Executive | Grant | Class A Common Stock | $0 | +39K +9.22% | 465,241 0.41% of shares | low |
| Jan 2, 2026 | Smith Jill D. Director | Grant | Class A Common Stock | $0 | +23K | 23,137 0.02% of shares | low |
| Jan 2, 2026 | Ramos Mario Executive | Grant | Class A Common Stock | $0 | +588K | 587,500 0.52% of shares | low |
| Mar 2, 2026 | Shams Aammaad Executive | Grant | Performance-Based Share Unit | — | +55K | 55,173 0.05% of shares | low |
| Mar 2, 2026 | Blackley Seth CEO | Grant | Performance-Based Share Unit | — | +1.4M | 1,425,310 1.26% of shares | low |
| Mar 2, 2026 | Weinberg Jonathan Executive | Grant | Performance-Based Share Unit | — | +180K | 179,661 0.16% of shares | low |
| Mar 2, 2026 | McCarthy Daniel Joseph Executive | Grant | Performance-Based Share Unit | — | +826K | 826,440 0.73% of shares | low |
| Mar 2, 2026 | Ramos Mario Executive | Grant | Performance-Based Share Unit | — | +429K | 429,041 0.38% of shares | low |